Condition: Celiac Disease · Sponsor: Chugai Pharmaceutical
The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
This description comes directly from the study's public registry record.
Clinical trials information · only use Email · clinical-trials@chugai-pharm.co.jp
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | Recruiting |
| Birmingham Digestive Health Research | Homewood, Alabama, United States | Recruiting |
| East View Medical Research | Mobile, Alabama, United States | Recruiting |
| Chandler Clinical Trials | Chandler, Arizona, United States | Recruiting |
| Research Solutions of Arizona, PC | Litchfield, Arizona, United States | Recruiting |
| One of a Kind Clinical Research Center LLC | Scottsdale, Arizona, United States | Recruiting |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | Recruiting |
| GMC Clinical Research, LLC | Folsom, California, United States | Recruiting |
| Velocity Clinical Research, Gardena | Gardena, California, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| Clinical Applications Laboratories | San Diego, California, United States | Recruiting |
| California Research Foundation | San Diego, California, United States | Recruiting |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07239336